Drug profile · INN
olmesartan + amlodipine + hydrochlorothiazide
SEVIKAR HCT 20/5/12.5
olmesartan + amlodipine + hydrochlorothiazide (SEVIKAR HCT 20/5/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — olmesartan + amlodipine + hydrochlorothiazide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
olmesartan + amlodipine + hydrochlorothiazide (SEVIKAR HCT 20/5/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
Key facts
INN olmesartan + amlodipine + hydrochlorothiazide
Brand SEVIKAR HCT 20/5/12.5
Originator Alphapharm Pty Ltd
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is olmesartan + amlodipine + hydrochlorothiazide?
olmesartan + amlodipine + hydrochlorothiazide (SEVIKAR HCT 20/5/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
What is the brand name for olmesartan + amlodipine + hydrochlorothiazide?
SEVIKAR HCT 20/5/12.5 is a marketed brand name for olmesartan + amlodipine + hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.